Dova picked up its newly approved drug castoff for a song — but payers will be singing the blues about the price
Dova $DOVA didn’t have to pay much when it bagged the rights to Doptelet (avatrombopag) from Eisai — laying out only $5 million for the castoff …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
